Logo image of MAPS.MI

MAPS SPA (MAPS.MI) Stock Fundamental Analysis

Europe - BIT:MAPS - IT0005364333 - Common Stock

3.43 EUR
+0.09 (+2.69%)
Last: 9/17/2025, 7:00:00 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to MAPS. MAPS was compared to 103 industry peers in the Software industry. MAPS has an average financial health and profitability rating. MAPS may be a bit undervalued, certainly considering the very reasonable score on growth These ratings would make MAPS suitable for value investing!


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

MAPS had positive earnings in the past year.
In the past year MAPS had a positive cash flow from operations.
MAPS had positive earnings in each of the past 5 years.
MAPS had a positive operating cash flow in each of the past 5 years.
MAPS.MI Yearly Net Income VS EBIT VS OCF VS FCFMAPS.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M

1.2 Ratios

MAPS has a Return On Assets of 3.47%. This is comparable to the rest of the industry: MAPS outperforms 50.49% of its industry peers.
The Return On Equity of MAPS (7.36%) is comparable to the rest of the industry.
Looking at the Return On Invested Capital, with a value of 7.56%, MAPS is in the better half of the industry, outperforming 64.08% of the companies in the same industry.
MAPS had an Average Return On Invested Capital over the past 3 years of 5.29%. This is significantly below the industry average of 12.80%.
The last Return On Invested Capital (7.56%) for MAPS is above the 3 year average (5.29%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.47%
ROE 7.36%
ROIC 7.56%
ROA(3y)3.32%
ROA(5y)3.66%
ROE(3y)8.11%
ROE(5y)9.49%
ROIC(3y)5.29%
ROIC(5y)4.69%
MAPS.MI Yearly ROA, ROE, ROICMAPS.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

The Profit Margin of MAPS (6.36%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of MAPS has declined.
MAPS's Operating Margin of 12.28% is fine compared to the rest of the industry. MAPS outperforms 62.14% of its industry peers.
MAPS's Operating Margin has been stable in the last couple of years.
Looking at the Gross Margin, with a value of 83.44%, MAPS is in the better half of the industry, outperforming 79.61% of the companies in the same industry.
In the last couple of years the Gross Margin of MAPS has grown nicely.
Industry RankSector Rank
OM 12.28%
PM (TTM) 6.36%
GM 83.44%
OM growth 3Y9.6%
OM growth 5Y0.31%
PM growth 3Y-15.7%
PM growth 5Y-12.24%
GM growth 3Y6.68%
GM growth 5Y1.59%
MAPS.MI Yearly Profit, Operating, Gross MarginsMAPS.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

More info and screens

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), MAPS is destroying value.
Compared to 1 year ago, MAPS has about the same amount of shares outstanding.
The number of shares outstanding for MAPS has been increased compared to 5 years ago.
Compared to 1 year ago, MAPS has an improved debt to assets ratio.
MAPS.MI Yearly Shares OutstandingMAPS.MI Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
MAPS.MI Yearly Total Debt VS Total AssetsMAPS.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

An Altman-Z score of 2.24 indicates that MAPS is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.24, MAPS perfoms like the industry average, outperforming 40.78% of the companies in the same industry.
The Debt to FCF ratio of MAPS is 3.61, which is a good value as it means it would take MAPS, 3.61 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 3.61, MAPS perfoms like the industry average, outperforming 59.22% of the companies in the same industry.
A Debt/Equity ratio of 0.24 indicates that MAPS is not too dependend on debt financing.
MAPS has a Debt to Equity ratio (0.24) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 3.61
Altman-Z 2.24
ROIC/WACC0.92
WACC8.18%
MAPS.MI Yearly LT Debt VS Equity VS FCFMAPS.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

2.3 Liquidity

A Current Ratio of 1.75 indicates that MAPS should not have too much problems paying its short term obligations.
MAPS has a better Current ratio (1.75) than 69.90% of its industry peers.
A Quick Ratio of 1.28 indicates that MAPS should not have too much problems paying its short term obligations.
MAPS's Quick ratio of 1.28 is in line compared to the rest of the industry. MAPS outperforms 54.37% of its industry peers.
Industry RankSector Rank
Current Ratio 1.75
Quick Ratio 1.28
MAPS.MI Yearly Current Assets VS Current LiabilitesMAPS.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 106.39% over the past year.
Measured over the past years, MAPS shows a decrease in Earnings Per Share. The EPS has been decreasing by -6.38% on average per year.
MAPS shows a decrease in Revenue. In the last year, the revenue decreased by -4.78%.
MAPS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.05% yearly.
EPS 1Y (TTM)106.39%
EPS 3Y-11.01%
EPS 5Y-6.38%
EPS Q2Q%143.34%
Revenue 1Y (TTM)-4.78%
Revenue growth 3Y7.92%
Revenue growth 5Y13.05%
Sales Q2Q%-3.8%

3.2 Future

MAPS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 37.40% yearly.
MAPS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.99% yearly.
EPS Next Y48.54%
EPS Next 2Y43.03%
EPS Next 3Y37.4%
EPS Next 5YN/A
Revenue Next Year12.82%
Revenue Next 2Y12.48%
Revenue Next 3Y11.96%
Revenue Next 5Y8.99%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MAPS.MI Yearly Revenue VS EstimatesMAPS.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 10M 20M 30M 40M
MAPS.MI Yearly EPS VS EstimatesMAPS.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.1 0.2 0.3 0.4

More info and screens

8

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 21.44 indicates a rather expensive valuation of MAPS.
82.52% of the companies in the same industry are more expensive than MAPS, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of MAPS to the average of the S&P500 Index (27.20), we can say MAPS is valued slightly cheaper.
MAPS is valuated correctly with a Price/Forward Earnings ratio of 14.15.
Based on the Price/Forward Earnings ratio, MAPS is valued cheaply inside the industry as 88.35% of the companies are valued more expensively.
MAPS is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.70, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 21.44
Fwd PE 14.15
MAPS.MI Price Earnings VS Forward Price EarningsMAPS.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MAPS is valued cheaper than 89.32% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, MAPS is valued cheaper than 88.35% of the companies in the same industry.
Industry RankSector Rank
P/FCF 12.36
EV/EBITDA 7.09
MAPS.MI Per share dataMAPS.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of MAPS may justify a higher PE ratio.
A more expensive valuation may be justified as MAPS's earnings are expected to grow with 37.40% in the coming years.
PEG (NY)0.44
PEG (5Y)N/A
EPS Next 2Y43.03%
EPS Next 3Y37.4%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MAPS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MAPS SPA

BIT:MAPS (9/17/2025, 7:00:00 PM)

3.43

+0.09 (+2.69%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners7.41%
Inst Owner ChangeN/A
Ins Owners50.83%
Ins Owner ChangeN/A
Market Cap45.55M
Analysts84.44
Price Target5.24 (52.77%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-4.93%
EPS NY rev (3m)-4.93%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.44%
Valuation
Industry RankSector Rank
PE 21.44
Fwd PE 14.15
P/S 1.53
P/FCF 12.36
P/OCF 6.37
P/B 1.77
P/tB 284.87
EV/EBITDA 7.09
EPS(TTM)0.16
EY4.66%
EPS(NY)0.24
Fwd EY7.07%
FCF(TTM)0.28
FCFY8.09%
OCF(TTM)0.54
OCFY15.69%
SpS2.24
BVpS1.94
TBVpS0.01
PEG (NY)0.44
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.47%
ROE 7.36%
ROCE 9.31%
ROIC 7.56%
ROICexc 9.01%
ROICexgc 40.37%
OM 12.28%
PM (TTM) 6.36%
GM 83.44%
FCFM 12.38%
ROA(3y)3.32%
ROA(5y)3.66%
ROE(3y)8.11%
ROE(5y)9.49%
ROIC(3y)5.29%
ROIC(5y)4.69%
ROICexc(3y)6.34%
ROICexc(5y)5.95%
ROICexgc(3y)24.88%
ROICexgc(5y)20.62%
ROCE(3y)6.51%
ROCE(5y)5.78%
ROICexcg growth 3Y27.03%
ROICexcg growth 5Y13.72%
ROICexc growth 3Y7.75%
ROICexc growth 5Y-2.25%
OM growth 3Y9.6%
OM growth 5Y0.31%
PM growth 3Y-15.7%
PM growth 5Y-12.24%
GM growth 3Y6.68%
GM growth 5Y1.59%
F-Score6
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 3.61
Debt/EBITDA 0.85
Cap/Depr 95.63%
Cap/Sales 11.63%
Interest Coverage 250
Cash Conversion 98.22%
Profit Quality 194.61%
Current Ratio 1.75
Quick Ratio 1.28
Altman-Z 2.24
F-Score6
WACC8.18%
ROIC/WACC0.92
Cap/Depr(3y)208.63%
Cap/Depr(5y)241.55%
Cap/Sales(3y)22.2%
Cap/Sales(5y)26.14%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)106.39%
EPS 3Y-11.01%
EPS 5Y-6.38%
EPS Q2Q%143.34%
EPS Next Y48.54%
EPS Next 2Y43.03%
EPS Next 3Y37.4%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.78%
Revenue growth 3Y7.92%
Revenue growth 5Y13.05%
Sales Q2Q%-3.8%
Revenue Next Year12.82%
Revenue Next 2Y12.48%
Revenue Next 3Y11.96%
Revenue Next 5Y8.99%
EBIT growth 1Y150.21%
EBIT growth 3Y18.28%
EBIT growth 5Y13.4%
EBIT Next Year163.44%
EBIT Next 3Y54.95%
EBIT Next 5Y41.94%
FCF growth 1Y221.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y28.2%
OCF growth 3Y29.34%
OCF growth 5Y59.94%